Stay updated on Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial
Sign up to get notified when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.

Latest updates to the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a page revision label (Revision: v3.4.2) and removed an older government-funding notice; these are administrative updates that do not affect the study data or access to trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding status notice about the NIH Clinical Center and operations. Updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded glossary toggle and updated page metadata to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.0%

- Check84 days agoChange DetectedNew location sections for multiple Italian sites (BA, BG, BO, FC, GE, ME, MI, PD, PI, SI, TO) have been added and the page revision updated to v3.3.3. The previous location blocks and the HHS Vulnerability Disclosure link have been removed.SummaryDifference1%

Stay in the know with updates to Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.